CARINA LEWIS: Open Payments
NPI 1457730665 · AURORA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 69 payments from 15 companies in 2025. Trend: 2023 $390 · 2024 $923 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $377 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $155 |
| Novo Nordisk Inc | 9 | $142 |
| PFIZER INC. | 6 | $103 |
| Axsome Therapeutics, Inc. | 1 | $99 |
| Lilly USA, LLC | 5 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Abbott Laboratories | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
Products named: VRAYLAR, CAPLYTA, Auvelity, UBRELVY, Ozempic, Kerendia, MOUNJARO, ELIQUIS.
Industry payments across IN — which companies pay providers there.
